DrugSpace Symposium Spring 2023

Connect the Dots for Future Drug Discovery

In our third virtual BioSolveIT DrugSpace Symposium, focus is placed on the recent trends that transform modern drug discovery: machine learning, artificial intelligence, neural networks, and processing big data.
Can recent developments live up to the hype around AI, or is there still a long way to go? This event brings researchers together who aim to discover future drug candidates from a myriad of data flows. An exciting journey lies ahead of us!

Medicinal chemists, decision makers, representatives of crop-, pharmaceutical-, and medicine-related businesses, undergraduates and PhD students, researchers — simply anyone interested in future technologies and state-of-the-art drug development — you are cordially invited to participate in this virtual event. Again, this BioSolveIT Symposium aims to be accessible to the entire global research community; BioSolveIT takes pride in thanking all brilliant speakers and participants for their contribution to the event in advance.

The third DrugSpace Symposium takes place on 24 and 25th May, 2023 — starting daily at 3 pm CEST/Berlin. Registration and participation is free-of-charge.

Register for free for the DrugSpace 2023 Symposium

DrugSpace 2023 Programme

Once again, we are very proud to host renowned experts in their fields from around the globe, contributing their knowledge to the scientific community.
DrugSpace 2023 Programme (PDF)

Follow Us on Social Media

Don't want to miss the latest BioSolveIT updates on upcoming events, success stories, and software updates?
Follow us on our social media channels, and be always up-to-date with the latest developments in the drug discovery community.
LinkedIn Youtube Twitter Facebook
Join the Chemical Space Club

Join the Chemical Space Club

Enthusiasts of Chemical Spaces are invited to join the Chemical Space Club on LinkedIn.

Share information, early announcements, publications, success stories, and anything else related to huge chemistry spaces and databases. Become a member, and feel free to contribute.
Learn More

Confirmed Speakers

  • Philippe Schwaller
    (École Polytechnique Fédérale de Lausanne)
    "AI-Accelerated Organic Synthesis"
  • Quentin Perron
    (Iktos)
    "Yes, You Should Use AI for Medicinal Chemistry"
  • Léa El Khoury
    (Qubit)
    "Application of Absolute Binding Free Energy Calculations to Predict the Binding Modes and Affinities of Protein-Protein Inhibitors"
  • Francesca Grisoni
    (Eindhoven University of Technology)
    "Deep Learning for Drug Discovery: Challenges and Opportunities"
  • Marcus Gastreich
    (BioSolveIT)
    "Claw Machines for Exploding Chemical Spaces"
  • Yurri Moroz
    (Chemspace)
    "Making Virtual REAL: Creation and Use of the Giga-Scale Chemical Spaces"
  • Dusan Petrovic
    (Nuvisan)
    "Virtual Screening for Multiple Modalities"
  • Connor Coley
    (Massachusetts Institute of Technology)
    "Learning to Navigate Synthetically Accessible Chemical Space"
  • Henry van den Bedem
    (Atomwise)
    "An Efficient Graph Generative Model for Navigating Ultra-Large Combinatorial Synthesis Libraries"
  • Nick Antonopoulos
    (DeepLab)
    "Scalable and High-Throughput Deep Neural Virtual Screening"
  • Lewis Martin
    (OpenBench)
    "Fast and Economical Hit Finding with Active Learning"
  • Daniel Kuhn
    (Merck)
    "You Can't Improve What You Don't Measure — Measuring ML/AI Impact in Drug Discovery Projects"
  • Christoph Grebner
    (Sanofi)
    "AI-Driven Mining of Accessible Chemical Spaces"

Latest news

category
Webinars
Accelerating Drug Discovery with AI — Small Molecules and Beyond
Thu, 19 Jun 2025, 16:00 CEST (Berlin)
Machine learning and AI are transforming drug discovery, impacting areas like target assessment, chemical space exploration, and compound optimization. At AstraZeneca, AI technologies such as protein folding and REINVENT push the boundaries of protein structure prediction and molecular ideation. Further, the field is advancing with PROTACs (proteolytic targeting chimeras), which...
Read on
category
Webinars
Hit Finding, Fast and Structure-Based — A Case Study on WRN Helicase
Thu, 05 Jun 2025, 16:00 CEST
BioSolveIT and Proteros invite to a joint webinar with the title: Hit Finding, Fast and Structure-Based — A Case Study on WRN Helicase Crystallographic Fragment Screening Combined with Fragment Evolution Using Chemical Space Docking™ into Enamine REAL The speakers will report on a highly cost-efficient, novel hit finding approach towards...
Read on
category
Software
Mode Highlight: SeeSAR's Idea Factory
May 28, 2025 11:06 CEST
We’re excited to spotlight the Inspirator Mode in SeeSAR – a feature designed to supercharge your creativity during hit and lead discovery. Whether you’re a medicinal chemist or computational expert, Inspirator highlights the most promising molecular decorations across hundreds of thousands of conformations. With just a few clicks, it guides...
Read on